---  
layout: startup_page  
title: "BioAge Labs"  
id: "bioagelabs.com"  
permalink: "/bioagelabsbioagelabs.com02132024/"  
website: "https://bioagelabs.com/"  
funding_round: "Series D"  
funding_amount: "$170M"  
investors: "Sofinnova Investments, Longitude Capital, RA Capital, Cormorant Asset Management, RTW Investments, SV Health Investors, OrbiMed Advisors, Sands Capital, Pivotal bioVenture Partners, Osage University Partners, Lilly Ventures, Amgen Ventures, Andreessen Horowitz"  
about: "BioAge Labs is a clinical-stage biotechnology company developing novel therapies for obesity and metabolic diseases by leveraging the biology of aging. Their lead program, azelaprag, is an oral drug designed to significantly increase weight loss and improve body composition when used with incretin therapies. The company's research is based on insights from its discovery platform utilizing human longevity data."  
markets: "Biotechnology, Therapeutics, Metabolic Disease, Obesity"  
hq: "Richmond, California, United States"  
founded_year: "2015"  
linkedin: "https://www.linkedin.com/company/bioage-labs"  
twitter: "https://twitter.com/bioagelabs"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/bioage-labs"  
pitchbook: "https://pitchbook.com/profiles/company/163867-24"  

date_display: "13-Feb-2024"  
date: "2024-02-13"

# SEO Optimization  
meta_title: "BioAge Labs - Series D Funding ($170M)"  
meta_description: "BioAge Labs, BioAge Labs is a clinical-stage biotechnology company developing novel therapies for obesity and metabolic diseases by leveraging the biology of aging..."  
meta_keywords: "BioAge Labs, Biotechnology, Therapeutics, Metabolic Disease, Obesity, Series D funding"  
canonical_url: "https://startup.projectstartups.com/bioagelabsbioagelabs.com02132024/"  
---